The immune response against herpesvirus is more prominent in the early stages of MS

被引:48
作者
Villoslada, P
Juste, C
Tintore, M
Llorenç, V
Codina, G
Pozo-Rosich, P
Montalban, X
机构
[1] Univ Navarra, Dept Neurol, Navarra 31008, Spain
[2] Hosp Gen Valle Hebron, Neuroimmunol Unit, Barcelona, Spain
[3] Hosp Gen Valle Hebron, Dept Microbiol, Barcelona, Spain
关键词
D O I
10.1212/01.WNL.0000069461.53733.F7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To assess antibody levels against human herpesvirus type 6 ( HHV- 6), Epstein- Barr virus ( EBV), and Chlamydia pneumoniae ( CP) in serum from individuals in the early and late phase of MS. Results: A strong association was found between anti- HHV- 6 immunoglobulin M antibodies and early MS ( clinically isolated syndromes at high risk for MS, and short duration active relapsing- remitting MS) when compared with healthy controls and secondary progressive MS. Moreover, in this group of patients, titers for anti- EBV immunoglobulin G were also elevated. The authors found no association between the levels of serum antibodies against CP and MS, nor did they detect the presence of DNA for these pathogens in the serum of patients with MS. Finally, serum from two patients with other inflammatory neurologic diseases also had elevated immunoglobulin M antibodies to HHV- 6, indicating that the presence of this antibody is not specific to MS. Conclusion: An immune response against herpesviruses such as HHV- 6 and EBV is associated with early MS.
引用
收藏
页码:1944 / 1948
页数:5
相关论文
共 32 条
[1]   Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients [J].
Ablashi, DV ;
Eastman, HB ;
Owen, CB ;
Roman, MM ;
Friedman, J ;
Zabriskie, JB ;
Peterson, DL ;
Pearson, GR ;
Whitman, JE .
JOURNAL OF CLINICAL VIROLOGY, 2000, 16 (03) :179-191
[2]   PATHOGENESIS OF MULTIPLE-SCLEROSIS - THE IMMUNE DIATHESIS AND THE ROLE OF VIRUSES [J].
ALLEN, I ;
BRANKIN, B .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (02) :95-105
[3]   Epstein-Barr virus antibodies and risk of multiple sclerosis -: A prospective study [J].
Ascherio, A ;
Munger, KL ;
Lennette, ET ;
Spiegelman, D ;
Hernán, MA ;
Olek, MJ ;
Hankinson, SE ;
Hunter, DJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (24) :3083-3088
[4]   Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
Miller, DH ;
Scheltens, P ;
Campi, A ;
Polman, CH ;
Comi, G ;
Ader, HJ ;
Losseff, N ;
Valk, J .
BRAIN, 1997, 120 :2059-2069
[5]   The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach [J].
Blumberg, BM ;
Mock, DJ ;
Powers, JM ;
Ito, M ;
Assouline, JG ;
Baker, JV ;
Chen, BJ ;
Goodman, AD .
JOURNAL OF CLINICAL VIROLOGY, 2000, 16 (03) :159-178
[6]   DETECTION OF CHLAMYDIA-PNEUMONIAE BY POLYMERASE CHAIN-REACTION [J].
CAMPBELL, LA ;
MELGOSA, MP ;
HAMILTON, DJ ;
KUO, CC ;
GRAYSTON, JT .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (02) :434-439
[7]   Viruses and multiple sclerosis [J].
Cermelli, C ;
Jacobson, S .
VIRAL IMMUNOLOGY, 2000, 13 (03) :255-267
[8]   PLAQUE-ASSOCIATED EXPRESSION OF HUMAN HERPESVIRUS-6 IN MULTIPLE-SCLEROSIS [J].
CHALLONER, PB ;
SMITH, KT ;
PARKER, JD ;
MACLEOD, DL ;
COULTER, SN ;
ROSE, TM ;
SCHULTZ, ER ;
BENNETT, JL ;
GARBER, RL ;
CHANG, M ;
SCHAD, PA ;
SEWART, PM ;
NOWINSKI, RC ;
BROWN, JP ;
BURMER, GC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7440-7444
[9]   Advances in immunology - Autoimmune diseases [J].
Davidson, A ;
Diamond, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (05) :340-350
[10]   Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity [J].
Dighiero, G ;
Rose, NR .
IMMUNOLOGY TODAY, 1999, 20 (09) :423-428